对蒂莫西综合征的反意义寡核酸治疗方法
Xiaoyu Chen1,2, Fikri Birey1,2,3, Min-Yin Li1,2
1Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Nature
|April 24, 2024
概括
在提摩西综合征 (TS) 模型中,反意义寡核酸 (ASO) 成功减少了8A外因子. 这种方法可以扭转神经缺陷,为TS型1 (TS1) 提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 发育生物学 发展生物学
背景情况:
- 蒂莫西综合征 (TS) 是一种严重的疾病,与CACNA1C基因有关,特别是8A.
- TS型1 (TS1) 呈现自闭症,和长QT综合征,源于CACNA1C外体8A.中的功能获取变异.
- 之前的研究确定了TS1中的神经元表型,包括受损的处理和内部神经元迁移.
研究的目的:
- 通过准CACNA1C外基8A.来研究反感性寡核酸 (ASOs) 作为TS1的治疗策略.
- 评估ASOs在纠正与疾病相关的细胞和电路缺陷中的有效性,在体外和体内.
主要方法:
- 开发ASOs以减少CACNA1C外8A.的包含.
- 使用人类细胞和患者衍生的皮质器官的体外研究.
- 在体内研究中,使用前脑组合物和移植平台进行了内ASO注射.
主要成果:
- ASO有效地降低了CACNA1C外因子8A在人体细胞中的含有,无论是体外还是体内.
- 由ASO介导的从8A外到8外的切换挽救了有机体中的细胞缺陷,并改善了神经元迁移.
- 在体内单次静脉内注射ASO,在患者神经元中挽救了调节失调和树收缩.
结论:
- 通过ASO抑制CACNA1C外体8A表达是一种有前途的治疗策略,用于提摩西综合征1型.
- 这项研究表明了基于多层干细胞的方法在遗传疾病中逆转神经病理生理学的潜力.
- 这些发现突显了体内ASO治疗的可行性,以纠正与疾病有关的神经元功能障碍.
更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
9.5K
07:47Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
Published on: October 29, 2019
18.5K
相关概念视频
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
